Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Symbol
KROS
Shares outstanding
30,620,051 shares
Disclosed Ownership
2,418,984 shares
Ownership
7.9%
Form type
SCHEDULE 13G
Filing time
22 Oct 2025, 21:26:29 UTC
Date of event
15 Oct 2025
Next filing
17 Feb 2026

Sponsored

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 7.9% ownership in Keros Therapeutics, Inc. Common Stock, par value $0.0001 per share (KROS) on 15 Oct 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G for Keros Therapeutics, Inc. Common Stock, par value $0.0001 per share (KROS).
  • Disclosed ownership: 7.9%.
  • Date of event: 15 Oct 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 22 Oct 2025, 21:26.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 7.9% 2,418,984 0 2,418,984 Kevin Tang Manager
KEVIN TANG 7.9% 2,418,984 0 2,418,984 Kevin Tang Self
TANG CAPITAL PARTNERS, LP 5.2% 1,579,237 0 1,579,237 Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP 2.7% 839,747 0 839,747 Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 0% 0 0 0 Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0% 0 0 0 Kevin Tang Chief Executive Officer